Berlin-Chemie AG is a German pharmaceutical company based in Berlin, Germany, that develops, manufactures, and distributes pharmaceutical products. As a wholly-owned subsidiary of the Italian Menarini Group since 1992, it serves as the regional headquarters for Central and Eastern Europe and the CIS region, managing operations in over 30 countries. The company focuses on therapeutic areas including cardiology, diabetes, respiratory diseases, and oncology.